The Journal of Bone and Joint Surgery (American). 2006;88:1431-1441.
doi:10.2106/JBJS.E.00381
© 2006 The Journal of Bone and Joint Surgery, Inc.
Recombinant Human BMP-2 and Allograft Compared with Autogenous Bone Graft for Reconstruction of Diaphyseal Tibial Fractures with Cortical Defects
A Randomized, Controlled Trial
Alan L. Jones, MD1,
Robert W. Bucholz, MD2,
Michael J. Bosse, MD3,
Sohail K. Mirza, MD, MPH4,
Thomas R. Lyon, MD5,
Lawrence X. Webb, MD6,
Andrew N. Pollak, MD7,
Jane Davis Golden, PT, MHP8,
Alexandre Valentin-Opran, MD8 the BMP-2 Evaluation in Surgery for Tibial TraumaAllograft
(BESTT-ALL) Study Group
1 Orthopaedic Trauma Association of North Texas, 3600 Gaston Avenue, Barnett
Tower, Suite 1101, Dallas, TX 75246
2 Department of Orthopaedic Surgery, University of Texas Southwestern Medical
Center, 5323 Harry Hines Boulevard, Dallas, TX 75235
3 Department of Orthopaedic Surgery, Carolinas Medical Center, P.O. Box 32861,
Charlotte, NC 28232
4 Department of Orthopaedics, Harborview Medical Center, University of
Washington, 325 Ninth Avenue, Seattle, WA 98104
5 Department of Trauma Services, Lutheran Medical Center, 150 55th Street,
Brooklyn, NY 11220
6 Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC
27157
7 Department of Orthopaedics, University of Maryland School of Medicine, 22
South Greene Street, Suite T3R54, Baltimore, MD 21201
8 Wyeth Research, 87 CambridgePark Drive, Cambridge, MA 02140. E-mail address
for J.D. Golden:
jdavis{at}wyeth.com
Investigation performed at University of Texas Southwestern Medical
Center, Dallas, Texas; University of Maryland School of Medicine, Baltimore,
Maryland; Carolinas Medical Center, Charlotte, North Carolina; Harborview
Medical Center, Seattle, Washington; Lutheran Medical Center, Brooklyn, New
York; and Wake Forest School of Medicine Medical Center, Winston-Salem, North
Carolina
In support of their research for or preparation of this manuscript, one or
more of the authors received grants or outside funding from Wyeth Research.
None of the authors received payments or other benefits or a commitment or
agreement to provide such benefits from a commercial entity. A commercial
entity (Wyeth Research) paid or directed, or agreed to pay or direct, benefits
to a research fund, foundation, educational institution, or other charitable
or nonprofit organization with which seven of the authors are affiliated or
associated. Two other authors are salaried employees of Wyeth Research.
A commentary is available with the electronic versions of this article,
on our web site
(www.jbjs.org)
and on our quarterly CD-ROM (call our subscription department, at
781-449-9780, to order the CD-ROM).
Background: Currently, the treatment of diaphyseal tibial fractures
associated with substantial bone loss often involves autogenous bone-grafting
as part of a staged reconstruction. Although this technique results in high
healing rates, the donor-site morbidity and potentially limited supply of
suitable autogenous bone in some patients are commonly recognized drawbacks.
The purpose of the present study was to investigate the benefit and safety of
the osteoinductive protein recombinant human bone morphogenetic protein-2
(rhBMP-2) when implanted on an absorbable collagen sponge in combination with
freeze-dried cancellous allograft.
Methods: Adult patients with a tibial diaphyseal fracture and a
residual cortical defect were randomly assigned to receive either autogenous
bone graft or allograft (cancellous bone chips) for staged reconstruction of
the tibial defect. Patients in the allograft group also received an onlay
application of rhBMP-2 on an absorbable collagen sponge. The clinical
evaluation of fracture-healing included an assessment of pain with full
weight-bearing and fracture-site tenderness. The Short Musculoskeletal
Function Assessment (SMFA) was administered before and after treatment.
Radiographs were used to document union, the presence of extracortical
bridging callus, and incorporation of the bone-graft material.
Results: Fifteen patients were enrolled in each group. The mean
length of the defect was 4 cm (range, 1 to 7 cm). Ten patients in the
autograft group and thirteen patients in the rhBMP-2/allograft group had
healing without further intervention. The mean estimated blood loss was
significantly less in the rhBMP-2/allograft group. Improvement in the SMFA
scores was comparable between the groups. No patient in the rhBMP-2/allograft
group had development of antibodies to BMP-2; one patient had development of
transient antibodies to bovine type-I collagen.
Conclusions: The present study suggests that rhBMP-2/allograft is
safe and as effective as traditional autogenous bone-grafting for the
treatment of tibial fractures associated with extensive traumatic diaphyseal
bone loss.
Level of Evidence: Therapeutic Level II. See Instructions
to Authors for a complete description of levels of evidence.

CiteULike Connotea Del.icio.us Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. N. K. Kwong and M. B. Harris
Recent Developments in the Biology of Fracture Repair
J. Am. Acad. Ortho. Surg.,
November 1, 2008;
16(11):
619 - 625.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Corrales, S. Morshed, M. Bhandari, and T. Miclau III
Variability in the Assessment of Fracture-Healing in Orthopaedic Trauma Studies
J. Bone Joint Surg. Am.,
September 1, 2008;
90(9):
1862 - 1868.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. K. Cannada, J. O. Anglen, M. T. Archdeacon, D. Herscovici Jr., and R. F. Ostrum
Avoiding Complications in the Care of Fractures of the Tibia
J. Bone Joint Surg. Am.,
August 1, 2008;
90(8):
1760 - 1768.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Kwan, B. J. Slater, D. C. Wan, and M. T. Longaker
Cell-based therapies for skeletal regenerative medicine
Hum. Mol. Genet.,
April 15, 2008;
17(R1):
R93 - R98.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Morshed and M. Bhandari
Clinical Trial Design in Fracture-Healing Research: Meeting the Challenge
J. Bone Joint Surg. Am.,
February 1, 2008;
90(Supplement_1):
55 - 61.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. M. Novicoff, A. Manaswi, M. V. Hogan, S. M. Brubaker, W. M. Mihalko, and K. J. Saleh
Critical Analysis of the Evidence for Current Technologies in Bone-Healing and Repair
J. Bone Joint Surg. Am.,
February 1, 2008;
90(Supplement_1):
85 - 91.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. Cole, T. Miclau III, and M. Bhandari
What's New in Orthopaedic Trauma
J. Bone Joint Surg. Am.,
November 1, 2007;
89(11):
2560 - 2577.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. V. Gulotta, C. Hidaka, S. A. Maher, M. E. Cunningham, and S. A. Rodeo
What's New in Orthopaedic Research
J. Bone Joint Surg. Am.,
September 1, 2007;
89(9):
2092 - 2101.
[Full Text]
[PDF]
|
 |
|
Letters to the Editor:
Read all Letters to the Editor
- Implication of BMPs in the development of tumors.
- Fabian Krause, et al.
- JBJS Online, 22 Jan 2008
[Full text]
- Ms. Davis Golden et al. respond to Dr. Krause et al.
- Jane Davis Golden, PT, MHP, et al.
- JBJS Online, 22 Jan 2008
[Full text]
|